Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Traditionally hep C transmits sexually mostly among HIV-positive men who have sex with men.
The anti-LGBT law barred students from getting medically accurate information about safe sex.
Descovy and Truvada were both highly effective and generally safe options for HIV prevention in a recent clinical trial.
About 60 percent of young people living with HIV don’t know their status.
However, this finding applied only to those in low- and middle-income nations.
“This is a step in the right direction, but more work needs to be done.”
Researchers believe that hepatitis C is spreading through sex from the HIV-positive population to those who don’t have HIV.
Informal PrEP users were more likely to take it intermittently and skip recommended medical tests.
Pharma sets the prices for HIV and hep C drugs very high. What happens to those prices along the supply chain?
The new federal plan to combat HIV has the audacious goal of cutting the annual infection rate by 90 percent by 2030.
Researchers were also able to make the first-ever estimate of the level of antibodies needed for protection against HIV.
The CDC holds the patents to Truvada-as-PrEP, but hasn’t asked for a dime in royalties from Gilead. This is costing taxpayers billions. Why?
Activists want future and retroactive royalties to pay for a national PrEP program.
We take a look at the first-ever release of comprehensive region-level PrEP use data in New York.
The Conference on Retroviruses and Opportunistic Infections in Seattle saw many important studies that are advancing the fight against HIV.
A study of young gay and bi men and trans women in Chicago found PrEP stigma was linked with lower rates of use of Truvada for prevention.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.